Luciano Frontini

1.6k total citations
16 papers, 943 citations indexed

About

Luciano Frontini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Luciano Frontini has authored 16 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Luciano Frontini's work include Cancer Treatment and Pharmacology (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Luciano Frontini is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Luciano Frontini collaborates with scholars based in Italy, Malaysia and United Kingdom. Luciano Frontini's co-authors include Ciro Gallo, Sergio Robbiati, Luigi Manzione, S. Cigolari, Francesco Perrone, Cesare Gridelli, Elena Piazza, Santi Barbera, Francesco Rosetti and Silvia Novello and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Luciano Frontini

16 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luciano Frontini Italy 10 615 360 167 163 119 16 943
Trine Lembrecht Jørgensen Denmark 12 409 0.7× 156 0.4× 194 1.2× 90 0.6× 99 0.8× 41 764
D. Galdermans Belgium 14 374 0.6× 444 1.2× 103 0.6× 138 0.8× 94 0.8× 35 781
Ronald J. Maggiore United States 21 532 0.9× 330 0.9× 521 3.1× 183 1.1× 216 1.8× 46 1.2k
Rebecca L. Olin United States 16 454 0.7× 112 0.3× 237 1.4× 233 1.4× 139 1.2× 61 1.1k
Andrew Scarfe Canada 12 452 0.7× 203 0.6× 178 1.1× 50 0.3× 392 3.3× 21 889
Goulnar Kasymjanova Canada 18 575 0.9× 501 1.4× 33 0.2× 63 0.4× 83 0.7× 56 1.0k
Y. Imbert France 8 208 0.3× 150 0.4× 305 1.8× 86 0.5× 250 2.1× 27 616
Anant Ramaswamy India 17 605 1.0× 514 1.4× 94 0.6× 75 0.5× 55 0.5× 190 1.2k
Sophie Paget‐Bailly France 20 400 0.7× 371 1.0× 31 0.2× 105 0.6× 50 0.4× 48 970
Louise Stanton United Kingdom 15 443 0.7× 138 0.4× 66 0.4× 55 0.3× 28 0.2× 36 856

Countries citing papers authored by Luciano Frontini

Since Specialization
Citations

This map shows the geographic impact of Luciano Frontini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luciano Frontini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luciano Frontini more than expected).

Fields of papers citing papers by Luciano Frontini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luciano Frontini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luciano Frontini. The network helps show where Luciano Frontini may publish in the future.

Co-authorship network of co-authors of Luciano Frontini

This figure shows the co-authorship network connecting the top 25 collaborators of Luciano Frontini. A scholar is included among the top collaborators of Luciano Frontini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luciano Frontini. Luciano Frontini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Riva, Silvia, Jane Bryce, Francesco De Lorenzo, et al.. (2019). Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol. BMJ Open. 9(9). e031485–e031485. 12 indexed citations
2.
Bryce, Jane, Silvia Riva, Massimo Di Maïo, et al.. (2019). Measuring financial toxicity of cancer in the Italian health care system: Initial results of the patient reported outcome for fighting financial toxicity of cancer project (proFFiT).. Journal of Clinical Oncology. 37(27_suppl). 91–91. 2 indexed citations
3.
Feo, Gianfranco De, Luciano Frontini, Antonio Pepe, et al.. (2015). Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research. Journal of Medical Ethics. 41(10). 799–803. 5 indexed citations
4.
Mandalà, Mario, Sandro Barni, Irene Floriani, et al.. (2008). Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: The ‘GISCAD-alternating schedule’ study findings. European Journal of Cancer. 45(1). 65–73. 46 indexed citations
5.
Gebbia, Vittorio, Cesare Gridelli, Claudio Verusio, et al.. (2008). Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. Lung Cancer. 63(2). 251–258. 27 indexed citations
6.
Nisticò, Cecilia, Emilio Bria, Biagio Agostara, et al.. (2006). Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II study. Anti-Cancer Drugs. 17(3). 345–351. 4 indexed citations
7.
Nisticò, Cecilia, F. Cognetti, Luciano Frontini, et al.. (2005). Weekly Docetaxel in Pretreated Metastatic Breast Cancer Patients: A Phase I-II Study. Oncology. 68(4-6). 356–363. 9 indexed citations
8.
9.
Maïo, Massimo Di, Cesare Gridelli, Ciro Gallo, et al.. (2005). Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials. The Lancet Oncology. 6(9). 669–677. 181 indexed citations
10.
Frontini, Luciano. (2002). An Interesting Antitumor Drug in the Elderly Patients over the Age of 70: Weekly Docetaxel. Tumori Journal. 88(1_suppl1). S41–S43. 1 indexed citations
11.
Gridelli, Cesare, S. Cigolari, Ciro Gallo, et al.. (2001). Activity and toxicity of gemcitabine and gemcitabine+vinorelbine in advanced non-small-cell lung cancer elderly patients. Lung Cancer. 31(2-3). 277–284. 103 indexed citations
12.
Martignoni, Giancarlo, et al.. (1998). Increasing Doses of 5-Fluorouracil and High-Dose Folinic ACID in the Treatment of Metastatic Colorectal Cancer. Tumori Journal. 84(6). 662–665. 11 indexed citations
13.
Clerici, M., Filippo de Marinis, Elena Piazza, et al.. (1998). Phase II Study of the Activity and Tolerability of a Combined Regimen of High-Dose Epirubicin and Cisplatin in Stage IIIb and IV Non-Small Cell Lung Cancer. Tumori Journal. 84(6). 669–672. 4 indexed citations
14.
Frontini, Luciano, et al.. (1996). Cisplatin-Vinorelbine Combination Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer. Tumori Journal. 82(1). 57–60. 10 indexed citations
15.
Maltoni, Marco, M Pirovano, Emanuela Scarpi, et al.. (1995). Prediction of survival of patients terminally III with cancer. Results of an Italian prospective multicentric study. Cancer. 75(10). 2613–2622. 162 indexed citations
16.
Barni, Sandro, et al.. (1994). Vinorelbine as Single Agent in Pretreated Patients with Advanced Breast Cancer. Tumori Journal. 80(4). 280–282. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Trine Lembrecht Jørgensen Breakdown of academic impact, for papers by D. Galdermans Breakdown of academic impact, for papers by Ronald J. Maggiore Breakdown of academic impact, for papers by Rebecca L. Olin Breakdown of academic impact, for papers by Andrew Scarfe Breakdown of academic impact, for papers by Goulnar Kasymjanova Breakdown of academic impact, for papers by Y. Imbert Breakdown of academic impact, for papers by Anant Ramaswamy Breakdown of academic impact, for papers by Sophie Paget‐Bailly Breakdown of academic impact, for papers by Louise Stanton
Rankless by CCL
2026